Grant received

  • 10:50

Immunicum AB (publ) is one of the companies that receives funding from Sweden’s Innovation Agency program “Forska&Väx” (Research&Grow). The program aims to strengthen the competitiveness of small and medium size enterprises and create growth and renewal of Swedish industry.

Immunicum receives 470 000 SEK from the Innovation Agency, which will be used to develop the company’s manufacturing process to meet industry standards. The project will be conducted in collaboration with the Cancer Center Karolinska which is contributing with unique expertise in the manufacturing of advanced cell therapies.

See more: Pressrelease – Sweden’s Innovation Agency supports cancer vaccine